profit from every $100 of sales.
$0$100
Beyond Air
$2.13-3.40% today
+49.0% in 1 year
1-year low $0.701-year high $39.00
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2024 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Beyond Air sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $3.71 million in 2025, with -$46.6 million of profit last year.
SalesProfit
Beyond Air vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Beyond Air | No profit yet | ||
 Boston Scientific | 22.2× · Fair price | ||
 Koninklijke Philips | 30.1× · Expensive | ||
 Steris | 32.8× · Expensive | ||
 Zimmer Biomet Holdings | 27.7× · Fair price |
AI analysis
An AI analyst reads Beyond Air's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 1 | 4 | |
| 0 | -1 | -1 | -2 | |
| -30 | -52 | -63 | -45 | |
| -43 | -58 | -59 | -42 | |
| -43 | -56 | -60 | -47 | |
| -33.60 | -37.20 | -36.40 | -13.80 | |
| – | – | -112.8% | -44.9% | |
| – | – | -5,436.3% | -1,202.1% | |
| – | – | -5,197.8% | -1,258.4% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 99 | 69 | 57 | 30 |
| Cash | 80 | 29 | 11 | 5 |
| Total debt | 3 | 4 | 18 | 12 |
| Total liabilities | 21 | 27 | 30 | 16 |
| 73 | 38 | 25 | 14 | |
| 1 | 1 | 2 | 3 | |
| -44.9% | -113.0% | -113.1% | -142.1% | |
| -59.4% | -147.2% | -240.5% | -343.3% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -23 | -33 | -56 | -38 | |
| 1 | 4 | 6 | 6 | |
| -25 | -37 | -62 | -44 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 8 | 20 | 21 | 9 |
Valuation
- –
- –
- –
- 0.5×
- 1.0×
- –
- –
- -1,242.7%
- -1,313.8%
- 0.0%
Profitability
- -44.9%
- -1,202.1%
- -1,258.4%
- -370.5%
- -90.3%
- -115.5%
- -279.6%
- -84.3%
- -91.4%
- 162.1%
Growth
- +219.7%
- –
- +28.6%
- –
- +39.3%
Financial health
- –
- 3.06
- 67.5%
- -10.2×
- 5.12
- 4.77
- 0.19
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 1%of 946
Top 1%of 868
What analysts expect
- Average price target
- $1.00
- Range
- $1.00 – $1.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Feb 13, 2026 | -0.85 | -0.75 | −13.3% |
| Nov 10, 2025 | -1.25 | -0.54 | −131.5% |
| Aug 12, 2025 | -1.53 | -1.50 | −2.0% |
| Jun 17, 2025 | -1.80 | -2.80 | +35.7% |
| Feb 10, 2025 | -3.00 | -0.24 | −1,150.0% |
| Nov 11, 2024 | -5.60 | -6.00 | +6.7% |
| Aug 6, 2024 | -5.40 | -5.80 | +6.9% |
| Jun 24, 2024 | -7.20 | -9.40 | +23.4% |
News
3 Data Center Infrastructure Stocks Retail Investors Are Watching Beyond NvidiaYahoo Finance · Nov 11, 20263 US AI Chip Stocks Beyond Nvidia Stock Key Person RiskYahoo Finance · Nov 10, 2026The stock-market rally keeps spreading beyond Big Tech. October inflation data could put it to the test.MarketWatch · Nov 9, 2026Why S&P 500 investors may want to look beyond mega-cap techYahoo Finance · Nov 9, 2026RLX Technology (RLX): Overseas Expansion Must Deliver Beyond a Revenue Pull-ForwardYahoo Finance · Nov 6, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
28No pass
Benjamin Graham
57No pass
Philip Fisher
31No pass
Peter Lynch
71Pass
Joel Greenblatt
0No pass
Charlie Munger
21No pass
Terry Smith
29No pass
Questions about Beyond Air
Is Beyond Air a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Beyond Air AI analysis
What does Beyond Air do?
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It is in Medical - Devices.
Does Beyond Air pay a dividend?
No. Beyond Air does not pay a dividend at the moment.
Is Beyond Air stock halal?
No. Beyond Air does not pass our halal screen: its debt is 330% of its market value, at or above the 33% limit. How we check
How has Beyond Air stock done over the past year?
Up 49.0% over the past twelve months, to $2.13. It traded between $0.70 and $39.00 and is 94.5% below its high.
Who are Beyond Air's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Beyond Air's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.